| Characteristic | Diabetic Foot Disorder | P-value2 | |
| DFI N (%) = 250 (58)1 | DFU N (%) = 182 (42)1 | ||
| Sex | |||
| Female | 60 (13.9) | 51 (11.8) |
0.40 |
| Male | 190 (44.0) | 131 (30.3) | |
| Age (range) | 62.2 (25 - 89) | 63.2 (30 - 91) | 0.40 |
| Duration of the ulcer (months) | |||
| Acute | 170 (42.4) | 114 (28.4) |
0.967 |
| Chronic | 71 (17.7) | 46 (11.5) | |
| PEDIS score | 6.45 | 6.11 | 0.080 |
| level of academic achievement (P2 = 0.01) | |||
| Diploma | 29 (10.0) | 22 (7.6) | 0.34 |
| Higher education | 74 (25.7) | 29 (10.0) | <0.05* |
| School | 71 (24.7) | 63 (21.9) | <0.05* |
| Duration of diabetes (years) | |||
| 0 - 10 | 72 (18.9) | 4211.0) | 0.30 |
| 11 - 20 | 104 (27.4) | 63 (16.6) | |
| 21 - 30 | 37 (9.7) | 36 (9.5) | |
| > 31 | 17 (4.5) | 9 (2.4) | |
| Antidiabetic treatment | |||
| Insulin | 109 (25.2) | 82 (19.0) | 0.34 |
| Insulin and oral agents | 74 (17.1) | 43 (10) | |
| Oral agents | 67 (15.5) | 57 (13.2) | |
| Diabetes mellitus | |||
| Type 1 | 8 | 7 | 0.04 |
| Type 2 | |||
| Prediabetes | 24 (5.9) | 18 (4.4) | 0.97
|
| Diabetes | 215 (52.7) | 151 (37.0) | |
| BMI (body mass index) | |||
| Underweight | 6 (1.9) | 5 (0.71) | 0.11 |
| Healthy | 50 (11.6) | 53 (12.3) | |
| Overweight | 103 (23.8) | 76 (17.6) | |
| Obesity Class 1 | 62(14.4) | 30(6.9) | |
| Obesity Class 2 | 26 (6.0) | 14 (3.2) | |
| Obesity Class 3 | 3 (0.69) | 4 (0.92) | |
| Imaging (P2 < 0.0001) | |||
| Charcot | 13 (3.0) | 6 (1.4) | NS |
| Osteomyelitis | 37 (8.6) | 14 (3.2) | <0.05* |
| Soft tissue swelling | 115 (26.6) | 58 (13.4) | <0.05* |
| No abnormality | 85 (19.0) | 104 (23.1) | <0.05* |
| Imaging vascular intervention (P2 = 0.02) | |||
| Angiogram | 54 (26.7) | 30 (14.9) | <0.05* |
| Angioplasty | 29 (14.4) | 40 (19.8) | <0.05* |
| Stenting | 25 (12.4) | 24 (11.9) | NS |
| Peripheral vascular disease | 157 (36.3%) | 113 (26.2) | 0.96 |
| Ambulatory CVA | 21 (4.7) | 25 (5.8) | 0.11 |
| Neuropathy | 162 (37.5) | 102 (23.6) | 0.08 |
| Retinopathy | 109 (31.6) | 66 (9.3) | 0.91 |
| Ischemic heart disease | 123 (28.5) | 88 (20.4) | 0.93 |
| Hypertension | 196 (45.4) | 144 (33.3) | 0.95 |
| Dyslipidemia | 145 (33.6) | 91 (21.1) | 0.12 |
| Antiplatelet | 179 (41.4) | 138 (31.9) | 0.38 |
| Statins | 151 (34.9) | 104 (24.1) | 0.56 |
| Urine microalbuminuria | 107 (24.8) | 62 (14.4) | 0.08 |
| Smoking | 124 (28.7) | 63 (14.6) | 0.003* |
| Immunosuppression | 16 (3.7) | 13 (3.0) | 0.91 |
| Nephropathy | 87 (25.8) | 58 (17.2) | 0.77 |